GB1496371A - 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof - Google Patents

4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof

Info

Publication number
GB1496371A
GB1496371A GB3424375A GB3424375A GB1496371A GB 1496371 A GB1496371 A GB 1496371A GB 3424375 A GB3424375 A GB 3424375A GB 3424375 A GB3424375 A GB 3424375A GB 1496371 A GB1496371 A GB 1496371A
Authority
GB
United Kingdom
Prior art keywords
amino
quinoline derivatives
preparation
halo
aug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3424375A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERDEX SAS
Original Assignee
SERDEX SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERDEX SAS filed Critical SERDEX SAS
Priority to GB3424375A priority Critical patent/GB1496371A/en
Priority to FR7624952A priority patent/FR2321291A1/fr
Priority to ES450995A priority patent/ES450995A1/es
Priority to BE169877A priority patent/BE845271A/xx
Publication of GB1496371A publication Critical patent/GB1496371A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3424375A 1975-08-18 1975-08-18 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof Expired GB1496371A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB3424375A GB1496371A (en) 1975-08-18 1975-08-18 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
FR7624952A FR2321291A1 (fr) 1975-08-18 1976-08-17 Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques
ES450995A ES450995A1 (es) 1975-08-18 1976-08-17 Procedimiento para la obtencion de nuevos derivados de la amino-4-quinoleina.
BE169877A BE845271A (fr) 1975-08-18 1976-08-18 Nouveaux derives de l'amino-4 quinoleine, leur preparation et leurs applications therapeutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3424375A GB1496371A (en) 1975-08-18 1975-08-18 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof

Publications (1)

Publication Number Publication Date
GB1496371A true GB1496371A (en) 1977-12-30

Family

ID=10363223

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3424375A Expired GB1496371A (en) 1975-08-18 1975-08-18 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof

Country Status (4)

Country Link
BE (1) BE845271A (https=)
ES (1) ES450995A1 (https=)
FR (1) FR2321291A1 (https=)
GB (1) GB1496371A (https=)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275520A1 (de) * 1986-12-31 1988-07-27 BASF Aktiengesellschaft Substituierte 1,8-Naphthyridin-Derivate und diese enthaltende Fungizide
US5102892A (en) * 1989-03-17 1992-04-07 Basf Aktiengesellschaft 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
US5145843A (en) * 1988-01-29 1992-09-08 Dowelanco Quinoline and cinnoline fungicides
US5296484A (en) * 1988-01-29 1994-03-22 Dowelanco Quinoline derivatives
WO1999037635A1 (en) * 1998-01-26 1999-07-29 Smithkline Beecham Plc Quinoline derivatives as antibacterials
WO2000021948A1 (en) * 1998-10-14 2000-04-20 Smithkline Beecham Plc Naphthrydine compounds and their azaisosteric analogues as antibacterials
WO2000078748A1 (en) * 1999-06-21 2000-12-28 Smithkline Beecham P.L.C. Quinoline derivatives as antibacterials
WO2001007433A3 (en) * 1999-07-23 2001-05-25 Smithkline Beecham Plc Quinoline derivatives and their use as antibacterial agents
WO2006034235A3 (en) * 2004-09-20 2006-12-21 Serenex Inc Substituted quinoline and quinazoline inhibitors of quinone reductase 2
JP2016506965A (ja) * 2013-02-01 2016-03-07 ウェルスタット セラピューティクス コーポレイション 抗炎症、抗真菌、抗寄生生物及び抗癌活性を有するアミン化合物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114727C (en) * 1991-08-02 1996-12-10 Mikel P. Moyer Quinoline derivatives as immunostimulants
IL118054A0 (en) * 1995-05-09 1996-08-04 Basf Ag (Het) aryloxy-,(-thio- and -amino-)-crotonates their preparation and pharmaceutical compositions containing them
WO2011036557A1 (en) * 2009-09-22 2011-03-31 The University Of British Columbia Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH49A (fr) * 1889-01-16 Allemand H E Système de canons-olives à rivure intérieure
CH58A (de) * 1889-01-08 F Bachschmid Neuerung an Ankerhemmungen
CH72A (de) * 1889-01-17 G Jun Meguin Neuerung an Kämmmaschinen
CH84A (fr) * 1889-01-10 Fontainemelon Horlogerie Perfectionnement apporté dans la construction des mécanismes de remontoir des montres de tous calibres

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801592A (en) * 1986-12-31 1989-01-31 Basf Aktiengesellschaft Substituted 1,8-naphthyridine derivatives and fungicides containing them
EP0275520A1 (de) * 1986-12-31 1988-07-27 BASF Aktiengesellschaft Substituierte 1,8-Naphthyridin-Derivate und diese enthaltende Fungizide
US5145843A (en) * 1988-01-29 1992-09-08 Dowelanco Quinoline and cinnoline fungicides
US5296484A (en) * 1988-01-29 1994-03-22 Dowelanco Quinoline derivatives
US5102892A (en) * 1989-03-17 1992-04-07 Basf Aktiengesellschaft 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom
WO1999037635A1 (en) * 1998-01-26 1999-07-29 Smithkline Beecham Plc Quinoline derivatives as antibacterials
WO2000021948A1 (en) * 1998-10-14 2000-04-20 Smithkline Beecham Plc Naphthrydine compounds and their azaisosteric analogues as antibacterials
US6911442B1 (en) 1999-06-21 2005-06-28 Smithkline Beecham P.L.C. Quinoline derivatives as antibacterials
WO2000078748A1 (en) * 1999-06-21 2000-12-28 Smithkline Beecham P.L.C. Quinoline derivatives as antibacterials
WO2001007433A3 (en) * 1999-07-23 2001-05-25 Smithkline Beecham Plc Quinoline derivatives and their use as antibacterial agents
US6989447B2 (en) 1999-07-23 2006-01-24 Smithkline Beecham P.L.C. Compounds
WO2006034235A3 (en) * 2004-09-20 2006-12-21 Serenex Inc Substituted quinoline and quinazoline inhibitors of quinone reductase 2
JP2016506965A (ja) * 2013-02-01 2016-03-07 ウェルスタット セラピューティクス コーポレイション 抗炎症、抗真菌、抗寄生生物及び抗癌活性を有するアミン化合物
CN108250142A (zh) * 2013-02-01 2018-07-06 维尔斯达医疗公司 具有抗炎、抗真菌、抗寄生物和抗癌活性的胺化合物
US10030015B2 (en) 2013-02-01 2018-07-24 Wellstat Therapeutics Corporation Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
RU2677229C2 (ru) * 2013-02-01 2019-01-16 Веллстат Терапьютикс Корпорейшн Соединения амина, имеющие противовоспалительную, противогрибковую, противопаразитарную и противораковую активность
US10934284B2 (en) 2013-02-01 2021-03-02 Wellstat Therapeutics Corporation Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
US12139483B2 (en) 2013-02-01 2024-11-12 Pharma Cinq, Llc Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

Also Published As

Publication number Publication date
ES450995A1 (es) 1977-09-01
BE845271A (fr) 1977-02-18
FR2321291A1 (fr) 1977-03-18
FR2321291B1 (https=) 1978-12-22

Similar Documents

Publication Publication Date Title
PT89047A (pt) Processo para a preparacao de derivados de piridazinamina
GB1496371A (en) 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
FI101624B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
DK182081A (da) Fremgangsmaade til fremstilling af hydroxaminsyrer
GB1467061A (en) Quinolines and process for their manufacture
AU2507088A (en) Amino acid derivatives of phosphorus acids
HUT40633A (en) Process for production of bicyclically condensated derivatives of oxasole and triasole-amin,substituated by 4-piperimidil-alkyl group
ATE61340T1 (de) Aminosaeurederivate und deren verfahren zur herstellung.
GB1466839A (en) Substituted phenylguanidines a process for their preparation and their use as medicaments
ATE59033T1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
HUT47241A (en) Process for producing alkyl-sulfonanilide derivatives and pharmaceuticals comprising them
FI873380A0 (fi) Foerfarande foer framstaellning av kinolinkarboxylsyror.
GB1456627A (en) Pyridobenzodiazepinones
GB1499189A (en) Substituted ammonium salts of 2-chloroethanephosphonic acid useful for influencing plant growth or behaviour
IE791490L (en) Phenyl-alkanoic acids
CS242088A2 (en) Method of 1-cyclopropyl-7-substituted-6-fluor-4-oxo-1,4-dihydroquinoline-3-carboxylic acid's derivatives production
HUT50352A (en) Process for producing new antiviral prine derivatives and pharmaceutical compositions comprising same
EP0224121A3 (en) 7-[4-amino-piperazinyl]- or 7-[4-chloro-piperazinyl]quinolinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
DE3068577D1 (en) 2-aminoalkyl-5-pyridinoles, process for their preparation and pharmaceutical preparations containing them
GR81771B (https=)
GB1469410A (en) Benzodioxole derivatives
GB1418854A (en) Cyclic sulphoximides
GB1435287A (en) Process for preparing a lysine-precursor

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee